文献速递血栓与止血

血清素释放试验阴性的肝素诱导性血小板减少症

Serotonin-release assay-negative heparin-induced thrombocytopenia.
PubMed 文献 · Am J Hematol · 2019-11-06

本研究基于队列研究数据,探讨了血清素释放试验(SRA)阴性但酶免疫分析(EIA)阳性的肝素诱导性血小板减少症(HIT)患者。在430例患者中,35例EIA阳性/SRA阳性,27例EIA阳性/SRA阴性;后者中3例经PF4增强SRA检测发现亚阈值血小板激活抗体,其中1例符合SRA阴性HIT临床标准。据此估算McMaster SRA诊断HIT的敏感性为35/36(97.2%;95% CI,85.8-99.9%)。

要点

  • SRA阴性HIT定义为:临床符合HIT(4Ts≥4分)、EIA阳性(≥1.00 units)、PF4-SRA阳性。
  • McMaster SRA对HIT诊断敏感性高(97.2%),但少数EIA阳性/SRA阴性患者仍可能为HIT。
  • 对高度怀疑HIT但SRA阴性的患者,可考虑PF4增强血小板激活试验辅助诊断。

核心结论

  • McMaster SRA对HIT诊断敏感性为35/36(97.2%;95% CI,85.8-99.9%)。
  • 少数EIA阳性/SRA阴性但临床高度怀疑HIT的患者,可通过PF4-SRA等PF4增强激活试验支持诊断。

研究设计与样本

  • 基于评估HIT临床和实验室诊断的队列研究,对EIA阳性患者进行PF4-SRA检测。
  • 共纳入430例患者,其中35例EIA阳性/SRA阳性,27例EIA阳性/SRA阴性。

主要发现

  • 27例EIA阳性/SRA阴性患者中,3例经PF4-SRA检出亚阈值血小板激活抗体。
  • 3例中1例符合SRA阴性HIT临床标准(4Ts≥4分、EIA≥1.00 units、PF4-SRA阳性)。

关键数值与推荐

  • SRA阴性HIT需满足:临床符合HIT(4Ts≥4分)、EIA阳性(≥1.00 units)、PF4-SRA阳性。
  • McMaster SRA诊断HIT敏感性为35/36(97.2%;95% CI,85.8-99.9%)。

临床怎么用

  • 对EIA阳性但SRA阴性且临床高度怀疑HIT的患者,可加做PF4-SRA辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is a prothrombotic drug reaction caused by platelet-activating anti-platelet factor 4 (PF4)/heparin antibodies. Pathogenic HIT antibodies can be detected by the serotonin-release assay (SRA), a platelet activation test. We have regarded the SRA performed in our medical community ("McMaster" SRA) as having high sensitivity and specificity. Recently, the concept of "SRA-negative HIT" has been proposed for enzyme-immunoassay (EIA)-positive/SRA-negative patients with a HIT-compatible clinical picture, who test positive in a PF4-enhanced platelet activation assay. After identifying an index case of SRA-negative HIT, we estimated the frequency of this condition by performing the "PF4-SRA" (modified SRA using high concentrations of added PF4 rather than heparin) in EIA-positive patients from a cohort study evaluating clinical and laboratory diagnosis of HIT. We defined SRA-negative HIT as patients meeting three criteria: clinical picture compatible with HIT (4Ts ≥ 4 points); EIA-positive (≥1.00 units); and PF4-SRA-positive. Among 430 patients, 35 were EIA-positive/SRA-positive and 27 were EIA-positive/SRA-negative. Among these 27 SRA-negative patients, three were found to have subthreshold levels of platelet-activating antibodies by PF4-SRA, of whom one met clinical criteria for SRA-negative HIT. Thus, based on identifying one patient with SRA-negative HIT within a cohort study that found 35 SRA-positive HIT patients, we estimate the sensitivity of the McMaster SRA for diagnosis of HIT to be 35/36 (97.2%; 95% CI, 85.8-99.9%). Although the McMaster SRA is highly sensitive for HIT, occasional SRA-negative but EIA-positive patients strongly suspected of having HIT can have this diagnosis supported by a PF4-enhanced activation assay such as the PF4-SRA.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Warkentin TE, Nazy I, Sheppard JI, et al. Serotonin-release assay-negative heparin-induced thrombocytopenia. Am J Hematol. 2019. PMID: 31621093. doi:10.1002/ajh.25660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。